<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04384809</url>
  </required_header>
  <id_info>
    <org_study_id>STUDY20200165</org_study_id>
    <nct_id>NCT04384809</nct_id>
  </id_info>
  <brief_title>Platelet Rich Plasma Injection vs Percutaneous Tenotomy for Common Extensor Tendinopathy</brief_title>
  <official_title>Comparison of Leukocyte-rich Platelet Rich Plasma Injection to Percutaneous Tenotomy in the Treatment of Chronic Common Extensor Tendinopathy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospitals Cleveland Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospitals Cleveland Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a randomized control trial comparing the use of leukocyte rich platelet rich plasma
      injections to percutaneous tenotomy for the treatment of chronic common extensor
      tendinopathy.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a randomized control trial comparing the use of leukocyte rich platelet rich plasma
      injections to percutaneous tenotomy for the treatment of chronic common extensor
      tendinopathy. Patients with a history of common extensor tendinopathy for greater than 3
      months, refractory to conservative treatments, are randomized into one of two groups:
      injection with leukocyte rich platelet rich plasma or percutaneous tenotomy with the Tenex
      system. Both groups of patients are followed up in clinic at 1 week, 2 weeks, 6 weeks, 3
      months, 6 months, and 1 year following the procedure to examine levels of pain or
      complications following both procedures.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">May 15, 2020</start_date>
  <completion_date type="Anticipated">May 1, 2022</completion_date>
  <primary_completion_date type="Anticipated">May 1, 2022</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Non-blinded, parallel randomized control trial</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in pain: visual analogue scale</measure>
    <time_frame>up to 12 months post-procedure</time_frame>
    <description>Change in pain will be measured using a 10 point visual analogue scale where 0 represents no pain and 10 indicates the worst pain possible.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in function</measure>
    <time_frame>up to 12 months post-procedure</time_frame>
    <description>Change in function will be measured using the Oxford Elbow score using a 48 point scale where a score of 0 indicates severe functional impairment and a score of 48 indicates no functional impairment</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Lateral Epicondylitis (Tennis Elbow)</condition>
  <arm_group>
    <arm_group_label>Leukocyte rich platelet rich plasma injection</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients will be injected with leukocyte rich platelet rich plasma in their common extensor tendon</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Percutaneous tenotomy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients will undergo percutaneous tenotomy of the common extensor tendon using the Tenex tenotomy device</description>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Leukocyte rich platelet rich plasma</intervention_name>
    <description>Leukocyte rich platelet rich plasma will be obtained and prepared from a peripheral artery of the subject and then will be injected in the common extensor tendon</description>
    <arm_group_label>Leukocyte rich platelet rich plasma injection</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Percutaneous Tenotomy</intervention_name>
    <description>Patients will undergo percutaneous tenotomy of the common extensor tendon using the Tenex tenotomy device</description>
    <arm_group_label>Percutaneous tenotomy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  At least 3 months of lateral elbow pain

          -  Subjectively failed trial of physical therapy and counterbracing

          -  Identifiable pathology on ultrasound (one or more of the following: thickened or
             disorganized tendon origin, microtearing, edema, neovascularization

        Exclusion Criteria:

          -  Steroid injection within the last 3 months

          -  Previous surgery for common extensor tendinopathy

          -  Current treatment with analgesics

          -  Pregnant, non-English speaking, or illiterate individuals

          -  History of anemia

          -  History of bleeding disorder

          -  Anticoagulant use

          -  History of cervical radiculopathy

          -  Hemoglobin less than 11 grams per deciliter

          -  Hematocrit less than 33%

          -  Platelet count outside of normal range of 150-400 x 1000 microliter
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>89 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Robert Flannery, MD</last_name>
    <phone>216-844-3078</phone>
    <email>Robert.Flannery@UHhospitals.org</email>
  </overall_contact>
  <verification_date>May 2020</verification_date>
  <study_first_submitted>May 7, 2020</study_first_submitted>
  <study_first_submitted_qc>May 11, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">May 12, 2020</study_first_posted>
  <last_update_submitted>May 11, 2020</last_update_submitted>
  <last_update_submitted_qc>May 11, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">May 13, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Hospitals Cleveland Medical Center</investigator_affiliation>
    <investigator_full_name>Robert Flannery, MD</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>common extensor</keyword>
  <keyword>lateral epicondyle</keyword>
  <keyword>tennis elbow</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tendinopathy</mesh_term>
    <mesh_term>Tennis Elbow</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

